about
Prevalence of obsessive-compulsive disorder in IranAn epidemiological survey of psychiatric disorders in Iran.Extended-release opioids in the management of cancer pain: a systematic review of efficacy and safety.A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death.Comparative Risk of Harm Associated With the Use of Targeted Immunomodulators: A Systematic Review.Selegiline in comparison with methylphenidate in attention deficit hyperactivity disorder children and adolescents in a double-blind, randomized clinical trial.Search strategies–identified reports on “off-label” drug use in MEDLINEInterventions to improve adverse drug reaction reporting: A scoping review
P50
Q24799843-51CBE631-2EFA-4327-AFF9-B5F5E30989C9Q24810639-C3BABA62-050C-461B-9672-C5E498704884Q35014155-4849270A-AAFF-4146-ACEB-F7B114757F88Q36203546-2E24073B-CEE7-4545-ACE2-8F5117753F23Q38668352-AE7BED90-F0AD-4409-BB25-5C68DB3ED670Q45223992-DC15228C-575E-4FDE-9BF6-B8EBBD586027Q63498861-F64E6EB3-E077-4457-986A-F76022243F98Q95282960-6A02E569-F5A2-4ED7-9E48-AB4AA86ADD1E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bita Mesgarpour
@ast
Bita Mesgarpour
@en
Bita Mesgarpour
@es
Bita Mesgarpour
@nl
Bita Mesgarpour
@sl
type
label
Bita Mesgarpour
@ast
Bita Mesgarpour
@en
Bita Mesgarpour
@es
Bita Mesgarpour
@nl
Bita Mesgarpour
@sl
prefLabel
Bita Mesgarpour
@ast
Bita Mesgarpour
@en
Bita Mesgarpour
@es
Bita Mesgarpour
@nl
Bita Mesgarpour
@sl
P106
P1153
7801349873
P21
P31
P496
0000-0002-4004-8493
P569
2000-01-01T00:00:00Z